Drug Class
Bruton's tyrosine kinase inhibitor
Type
ingredient
Active Ingredient
ibrutinib
📋Overview
Ibrutinib is a targeted therapy drug that interferes with specific proteins involved in the growth and survival of certain cancer cells. It is most commonly associated with the treatment of blood cancers such as chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenström's macroglobulinemia. By blocking a protein called Bruton's tyrosine kinase, ibrutinib helps slow the progression of these diseases. Its use represents a significant advancement in the management of some hematologic malignancies.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Ibrutinib
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.